- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06345729
Um estudo de MK-1084 Plus Pembrolizumabe (MK-3475) em participantes com câncer de pulmão de células não pequenas metastático KRAS G12C mutante (NSCLC) com ligante de morte celular programada 1 (PD-L1) Pontuação de proporção de tumor (TPS) ≥50% (MK-1084-004)
Um estudo de fase 3, randomizado, duplo-cego e multicêntrico de MK-1084 em combinação com pembrolizumabe em comparação com pembrolizumabe mais placebo como tratamento de primeira linha de participantes com KRAS G12C-mutante, NSCLC metastático com PD-L1 TPS ≥50%
This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There is one primary study hypothesis:
Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Per Protocol Amendment 04, overall survival (OS) was moved to be a secondary outcome measure. Additionally, no new participants will be offered Second Course treatment for pembrolizumab.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 3
Contactos e Locais
Contato de estudo
- Nome: Toll Free Number
- Número de telefone: 1-888-577-8839
- E-mail: Trialsites@msd.com
Locais de estudo
-
-
Baden-Wurttemberg
-
Stuttgart, Baden-Wurttemberg, Alemanha, 70199
- Recrutamento
- Marienhospital Stuttgart ( Site 1302)
-
Contato:
- Study Coordinator
- Número de telefone: +49711064893273
-
-
Mecklenburg-Vorpommern
-
Greifswald, Mecklenburg-Vorpommern, Alemanha, 17489
- Recrutamento
- Universitätsmedizin Greifswald ( Site 1308)
-
Contato:
- Study Coordinator
- Número de telefone: +4938348622006
-
-
North Rhine-Westphalia
-
Bielefeld, North Rhine-Westphalia, Alemanha, 33611
- Recrutamento
- Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
-
Contato:
- Study Coordinator
- Número de telefone: 0521 772 75504
-
Solingen, North Rhine-Westphalia, Alemanha, 42699
- Recrutamento
- Krankenhaus Bethanien ( Site 1303)
-
Contato:
- Study Coordinator
- Número de telefone: +49212636661
-
-
-
-
Buenos Aires
-
Berazategui, Buenos Aires, Argentina, B1884BBF
- Recrutamento
- Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
-
Contato:
- Study Coordinator
- Número de telefone: +541142262013
-
CABA, Buenos Aires, Argentina, C1019ABS
- Concluído
- AUSTRAL MEDICAL CENTER ( Site 0302)
-
CABA, Buenos Aires, Argentina, C1426AGE
- Recrutamento
- Centro Oncologico Korben ( Site 0304)
-
Contato:
- Study Coordinator
- Número de telefone: 1157507952
-
Mar del Plata, Buenos Aires, Argentina, B7600FZO
- Recrutamento
- Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
-
Contato:
- Study Coordinator
- Número de telefone: 02234963224
-
-
Río Negro Province
-
Viedma, Río Negro Province, Argentina, R8500ACE
- Recrutamento
- Clinica Viedma S. A ( Site 0307)
-
Contato:
- Study Coordinator
- Número de telefone: +54 2920 42-8700
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, S2000DEJ
- Recrutamento
- Fundacion Estudios Clinicos ( Site 0306)
-
Contato:
- Study Coordinator
- Número de telefone: +543412221472
-
Rosario, Santa Fe Province, Argentina, S2000DSV
- Recrutamento
- Sanatorio Parque ( Site 0301)
-
Contato:
- Study Coordinator
- Número de telefone: +54341420-0222
-
-
-
-
New South Wales
-
Camperdown, New South Wales, Austrália, 2050
- Recrutamento
- Chris O'Brien Lifehouse ( Site 3000)
-
Contato:
- Study Coordinator
- Número de telefone: +61285140140
-
-
Queensland
-
Urraween, Queensland, Austrália, 4655
- Recrutamento
- Cancer Care Service Hervey Bay ( Site 3003)
-
Contato:
- Study Coordinator
- Número de telefone: +610743256110
-
-
Victoria
-
Frankston, Victoria, Austrália, 3199
- Recrutamento
- Frankston Hospital ( Site 3002)
-
Contato:
- Study Coordinator
- Número de telefone: +61397847777
-
-
Western Australia
-
Nedlands, Western Australia, Austrália, 6009
- Recrutamento
- One Clinical Research ( Site 3001)
-
Contato:
- Study Coordinator
- Número de telefone: +61862799466
-
-
-
-
-
Rio de Janeiro, Brasil, 22775-001
- Recrutamento
- Americas ( Site 0431)
-
Contato:
- Study Coordinator
- Número de telefone: +552133852088
-
Rio de Janeiro, Brasil, 20230-130
- Recrutamento
- Instituto Nacional de Câncer - INCA ( Site 0446)
-
Contato:
- Study Coordinator
- Número de telefone: +552132076564
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasil, 30380-472
- Recrutamento
- Hospital Mario Penna ( Site 0436)
-
Contato:
- Study Coordinator
- Número de telefone: +553132999543
-
-
Pernambuco
-
Recife, Pernambuco, Brasil, 50040-000
- Recrutamento
- Hospital de Câncer de Recife ( Site 0447)
-
Contato:
- Study Coordinator
- Número de telefone: +558132178084
-
-
Piauí
-
Teresina, Piauí, Brasil, 64049-200
- Concluído
- Oncoclínica Oncologistas Associados ( Site 0441)
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, Brasil, 59062-000
- Recrutamento
- Liga Norte Riograndense Contra o Câncer ( Site 0439)
-
Contato:
- Study Coordinator
- Número de telefone: +558440095595
-
-
Rio Grande do Sul
-
Ijuí, Rio Grande do Sul, Brasil, 98700 000
- Recrutamento
- Hospital de Caridade de Ijuí ( Site 0438)
-
Contato:
- Study Coordinator
- Número de telefone: +5555991221138
-
Passo Fundo, Rio Grande do Sul, Brasil, 99010-260
- Recrutamento
- Hospital de Clínicas de Passo Fundo ( Site 0442)
-
Contato:
- Study Coordinator
- Número de telefone: +5554981271411
-
Porto Alegre, Rio Grande do Sul, Brasil, 90050-170
- Recrutamento
- Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
-
Contato:
- Study Coordinator
- Número de telefone: +555132148143
-
-
São Paulo
-
Barretos, São Paulo, Brasil, 14784-400
- Recrutamento
- Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
-
Contato:
- Study Coordinator
- Número de telefone: +551733216638
-
-
-
-
-
Pleven, Bulgária, 5804
- Recrutamento
- MHAT - Heart and Brain ( Site 1006)
-
Contato:
- Study Coordinator
- Número de telefone: +35988030371
-
Plovdiv, Bulgária, 4000
- Recrutamento
- Medical Center Futuremeds ( Site 1007)
-
Contato:
- Study Coordinator
- Número de telefone: +359886744494
-
Plovdiv, Bulgária, 4004
- Recrutamento
- Complex Oncology Center - Plovdiv EOOD ( Site 1003)
-
Contato:
- Study Coordinator
- Número de telefone: +359 32 277 240
-
-
Pazardzhik
-
Panagyurishte, Pazardzhik, Bulgária, 4500
- Recrutamento
- MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
-
Contato:
- Study Coordinator
- Número de telefone: +35935788581
-
-
Sofia (stolitsa)
-
Sofia, Sofia (stolitsa), Bulgária, 1632
- Recrutamento
- Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
-
Contato:
- Study Coordinator
- Número de telefone: +35929049100
-
-
-
-
Manitoba
-
Winnipeg, Manitoba, Canadá, R3E 0V9
- Recrutamento
- CancerCare Manitoba ( Site 0210)
-
Contato:
- Study Coordinator
- Número de telefone: 204-787-4156
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canadá, B3H 2Y9
- Recrutamento
- QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
-
Contato:
- Study Coordinator
- Número de telefone: 9024737964
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8V 5C2
- Recrutamento
- Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
-
Contato:
- Study Coordinator
- Número de telefone: 9053879495
-
Toronto, Ontario, Canadá, M4N 3M5
- Recrutamento
- Sunnybrook Research Institute ( Site 0206)
-
Contato:
- Study Coordinator
- Número de telefone: 4164805000x687435
-
-
Quebec
-
Montreal, Quebec, Canadá, H3T 1M5
- Recrutamento
- St. Marys Hospital Center ( Site 0204)
-
Contato:
- Study Coordinator
- Número de telefone: 5143453511
-
Trois-Rivières, Quebec, Canadá, G8Z 3R9
- Recrutamento
- Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
-
Contato:
- Study Coordinator
- Número de telefone: 8196973333x63238
-
-
-
-
Maule Region
-
Talca, Maule Region, Chile, 3465584
- Recrutamento
- Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
-
Contato:
- Study Coordinator
- Número de telefone: +56947532700
-
-
Region M. de Santiago
-
Santiago, Region M. de Santiago, Chile, 7500713
- Recrutamento
- Orlandi Oncologia-Oncology ( Site 0503)
-
Contato:
- Study Coordinator
- Número de telefone: +56226057491
-
Santiago, Region M. de Santiago, Chile, 7500921
- Recrutamento
- FALP-UIDO ( Site 0501)
-
Contato:
- Study Coordinator
- Número de telefone: +56224205098
-
Santiago, Region M. de Santiago, Chile, 8420383
- Recrutamento
- Bradfordhill-Clinical Area ( Site 0504)
-
Contato:
- Study Coordinator
- Número de telefone: +56229490970
-
Santiago, Region M. de Santiago, Chile, 7560913
- Recrutamento
- Centro de Oncología de Precisión ( Site 0502)
-
Contato:
- Study Coordinator
- Número de telefone: 56991612199
-
-
-
-
Anhui
-
Hefei, Anhui, China, 230031
- Ativo, não recrutando
- Anhui Provincial Cancer Hospital ( Site 3136)
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100142
- Ativo, não recrutando
- Beijing Cancer hospital ( Site 3133)
-
Beijing, Beijing Municipality, China, 100142
- Ativo, não recrutando
- Beijing Cancer hospital ( Site 3134)
-
Beijing, Beijing Municipality, China, 100730
- Ativo, não recrutando
- Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
-
Beijing, Beijing Municipality, China, 101149
- Ativo, não recrutando
- Beijing Chest Hospital,Capital Medical University ( Site 3104)
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, China, 400030
- Ativo, não recrutando
- Chongqing University Cancer Hospital ( Site 3119)
-
Chongqing, Chongqing Municipality, China, 400042
- Concluído
- Army Medical Center of People's Liberation Army ( Site 3142)
-
-
Fujian
-
Fuzhou, Fujian, China, 350014
- Ativo, não recrutando
- Fujian Cancer Hospital ( Site 3127)
-
Xiamen, Fujian, China, 361003
- Ativo, não recrutando
- The First Affiliated hospital of Xiamen University ( Site 3148)
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510160
- Concluído
- The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
-
Guangzhou, Guangdong, China, 510515
- Ativo, não recrutando
- Southern Medical University Nanfang Hospital ( Site 3128)
-
Guangzhou, Guangdong, China, 510555
- Concluído
- Sun Yat-sen University Cancer Center ( Site 3137)
-
-
Heilongjiang
-
Harbin, Heilongjiang, China, 150081
- Ativo, não recrutando
- Harbin Medical University Cancer Hospital ( Site 3123)
-
Jiamusi, Heilongjiang, China, 154007
- Ativo, não recrutando
- JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
-
-
Henan
-
Zhengzhou, Henan, China, 450008
- Ativo, não recrutando
- Henan Cancer Hospital ( Site 3149)
-
-
Hubei
-
Wuhan, Hubei, China, 430000
- Ativo, não recrutando
- Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
-
Wuhan, Hubei, China, 430079
- Ativo, não recrutando
- Hubei Cancer Hospital ( Site 3126)
-
-
Hunan
-
Changsha, Hunan, China, 410011
- Concluído
- The Second Xiangya Hospital of Central South University ( Site 3130)
-
Changsha, Hunan, China, 410013
- Ativo, não recrutando
- Hunan Cancer Hospital ( Site 3141)
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210008
- Ativo, não recrutando
- Nanjing Gulou Hospital ( Site 3122)
-
Nanjing, Jiangsu, China, 210012
- Concluído
- Nanjing First Hospital ( Site 3154)
-
Suzhou, Jiangsu, China, 215006
- Concluído
- The First Affiliated Hospital of Soochow University ( Site 3146)
-
Wuxi, Jiangsu, China, 214122
- Ativo, não recrutando
- Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
-
-
Jiangxi
-
Nanchang, Jiangxi, China, 330000
- Concluído
- The Second Affiliated Hospital of Nanchang University ( Site 3139)
-
Nanchang, Jiangxi, China, 330006
- Ativo, não recrutando
- The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
-
-
Jilin
-
Changchun, Jilin, China, 130012
- Ativo, não recrutando
- Jilin Province Tumor Hospital ( Site 3107)
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710000
- Concluído
- The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
-
-
Shandong
-
Jinan, Shandong, China, 250117
- Ativo, não recrutando
- Shandong Cancer Hospital ( Site 3116)
-
Linyi, Shandong, China, 276001
- Ativo, não recrutando
- LinYi Cancer Hospital ( Site 3111)
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200030
- Ativo, não recrutando
- Shanghai Chest Hospital ( Site 3100)
-
Shanghai, Shanghai Municipality, China, 200032
- Ativo, não recrutando
- Fudan University Shanghai Cancer Center ( Site 3144)
-
Shanghai, Shanghai Municipality, China, 200032
- Ativo, não recrutando
- Zhongshan Hospital,Fudan University ( Site 3143)
-
-
Shanxi
-
Taiyuan, Shanxi, China, 030000
- Ativo, não recrutando
- Shanxi Cancer Hospital ( Site 3131)
-
Xian, Shanxi, China, 710038
- Concluído
- The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
-
Xian, Shanxi, China, 710038
- Ativo, não recrutando
- The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
-
-
Sichuan
-
Chengdu, Sichuan, China, 610000
- Ativo, não recrutando
- West China Hospital, Sichuan University ( Site 3140)
-
Chengdu, Sichuan, China, 610031
- Ativo, não recrutando
- The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
-
Chengdu, Sichuan, China, 610042
- Ativo, não recrutando
- Sichuan Cancer hospital. ( Site 3109)
-
Neijiang, Sichuan, China, 641000
- Ativo, não recrutando
- The Second People's Hospital of Neijiang ( Site 3105)
-
-
Xinjiang
-
Ürümqi, Xinjiang, China, 830000
- Concluído
- Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
-
-
Yunnan
-
Kunming, Yunnan, China, 650107
- Ativo, não recrutando
- Yunnan Province Cancer Hospital ( Site 3153)
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310006
- Ativo, não recrutando
- The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
-
Hangzhou, Zhejiang, China, 310016
- Ativo, não recrutando
- Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
-
Linhai, Zhejiang, China, 317000
- Ativo, não recrutando
- Taizhou Hospital of Zhejiang Province ( Site 3145)
-
Wenzhou, Zhejiang, China, 325015
- Ativo, não recrutando
- The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
-
-
-
-
Cesar Department
-
Valledupar, Cesar Department, Colômbia, 200001
- Recrutamento
- Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
-
Contato:
- Study Coordinator
- Número de telefone: +573122354788
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colômbia, 110111
- Recrutamento
- Clinica Oncologica Colsubsidio ( Site 4003)
-
Contato:
- Study Coordinator
- Número de telefone: +573142059194
-
-
Risaralda Department
-
Pereira, Risaralda Department, Colômbia, 660001
- Recrutamento
- Oncologos del Occidente ( Site 4005)
-
Contato:
- Study Coordinator
- Número de telefone: +57 3187715522
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Colômbia, 76001
- Recrutamento
- Hemato Oncologos SA ( Site 4002)
-
Contato:
- Study Coordinator
- Número de telefone: +573167711932
-
-
-
-
-
Incheon, Coréia do Sul, 22332
- Recrutamento
- Inha University Hospital ( Site 3610)
-
Contato:
- Study Coordinator
- Número de telefone: +82328901038
-
Seoul, Coréia do Sul, 02447
- Recrutamento
- Kyung Hee University Hospital ( Site 3605)
-
Contato:
- Study Coordinator
- Número de telefone: 82-2-958-8511
-
Seoul, Coréia do Sul, 08308
- Recrutamento
- Korea University Guro Hospital ( Site 3601)
-
Contato:
- Study Coordinator
- Número de telefone: +82226261914
-
Seoul, Coréia do Sul, 03312
- Recrutamento
- The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
-
Contato:
- Study Coordinator
- Número de telefone: +82220304340
-
Seoul, Coréia do Sul, 02841
- Recrutamento
- Korea University Anam Hospital ( Site 3609)
-
Contato:
- Study Coordinator
- Número de telefone: +8229206409
-
-
Incheon
-
Bupyeong-gu, Incheon, Coréia do Sul, 21431
- Recrutamento
- The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
-
Contato:
- Study Coordinator
- Número de telefone: +82-32-280-6474
-
-
Jeonranamdo
-
Hwasun, Jeonranamdo, Coréia do Sul, 58128
- Concluído
- Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
-
-
Kyonggi-do
-
Suwon, Kyonggi-do, Coréia do Sul, 16247
- Recrutamento
- The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
-
Contato:
- Study Coordinator
- Número de telefone: 82-31-244-7983
-
-
Kyongsangnam-do
-
Yangsan, Kyongsangnam-do, Coréia do Sul, 50612
- Recrutamento
- Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
-
Contato:
- Study Coordinator
- Número de telefone: +82-55-360-1415
-
-
Taegu-Kwangyokshi
-
Daegu, Taegu-Kwangyokshi, Coréia do Sul, 42415
- Recrutamento
- Yeungnam University Hospital ( Site 3607)
-
Contato:
- Study Coordinator
- Número de telefone: +82536203848
-
Daegu, Taegu-Kwangyokshi, Coréia do Sul, 42601
- Recrutamento
- Keimyung University Dongsan Hospital ( Site 3611)
-
Contato:
- Study Coordinator
- Número de telefone: +82532587737
-
-
Taejon-Kwangyokshi
-
Junggu, Taejon-Kwangyokshi, Coréia do Sul, 35015
- Recrutamento
- Chungnam national university hospital ( Site 3602)
-
Contato:
- Study Coordinator
- Número de telefone: 82-42-257-5753
-
-
-
-
-
San José, Costa Rica, 10103
- Recrutamento
- Onco Tech, S.A. ( Site 4102)
-
Contato:
- Study Coordinator
- Número de telefone: +50622586260
-
-
-
-
-
Barcelona, Espanha, 08035
- Recrutamento
- Hospital Universitari Vall d Hebron ( Site 2010)
-
Contato:
- Study Coordinator
- Número de telefone: +34 932 543 450
-
Madrid, Espanha, 28040
- Recrutamento
- Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
-
Contato:
- Study Coordinator
- Número de telefone: 34915504800x253900
-
Madrid, Espanha, 28006
- Recrutamento
- Hospital Universitario La Princesa ( Site 2020)
-
Contato:
- Study Coordinator
- Número de telefone: +34915202200
-
Málaga, Espanha, 29010
- Recrutamento
- Hospital Universitario Virgen de la Victoria ( Site 2021)
-
Contato:
- Study Coordinator
- Número de telefone: 0034671594566
-
Seville, Espanha, 41009
- Recrutamento
- Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
-
Contato:
- Study Coordinator
- Número de telefone: 34954712941
-
-
Barcelona
-
Vic, Barcelona, Espanha, 08500
- Recrutamento
- H. General de Vic ( Site 2022)
-
Contato:
- Study Coordinator
- Número de telefone: +34937027732
-
-
Las Palmas
-
Las Palmas de Gran Canaria, Las Palmas, Espanha, 35001
- Recrutamento
- Hospital Insular de Gran Canaria-Oncology ( Site 2019)
-
Contato:
- Study Coordinator
- Número de telefone: +34 928441738
-
-
Madrid, Comunidad de
-
Leganés, Madrid, Comunidad de, Espanha, 28911
- Recrutamento
- Hospital Universitario Severo Ochoa ( Site 2024)
-
Contato:
- Study Coordinator
- Número de telefone: +34914818000
-
Madrid, Madrid, Comunidad de, Espanha, 28009
- Recrutamento
- HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
-
Contato:
- Study Coordinator
- Número de telefone: +34 915868115
-
-
Malaga
-
Málaga, Malaga, Espanha, 29011
- Recrutamento
- H.R.U Málaga - Hospital General-Oncology ( Site 2014)
-
Contato:
- Study Coordinator
- Número de telefone: +34 951308130
-
-
-
-
California
-
Bakersfield, California, Estados Unidos, 93309
- Recrutamento
- CBCC Global Research, Inc. ( Site 0123)
-
Contato:
- Study Coordinator
- Número de telefone: 661-322-2206
-
Beverly Hills, California, Estados Unidos, 90211
- Recrutamento
- Beverly Hills Cancer Center ( Site 0116)
-
Contato:
- Study Coordinator
- Número de telefone: 310-432-8955
-
-
Connecticut
-
Stamford, Connecticut, Estados Unidos, 06902
- Recrutamento
- Stamford Hospital ( Site 0136)
-
Contato:
- Study Coordinator
- Número de telefone: 877-233-9355
-
-
Florida
-
Miami Beach, Florida, Estados Unidos, 33140
- Concluído
- Mount Sinai Cancer Center ( Site 0137)
-
-
Illinois
-
Skokie, Illinois, Estados Unidos, 60077
- Recrutamento
- Orchard Healthcare Research Inc. ( Site 0115)
-
Contato:
- Study Coordinator
- Número de telefone: 224-534-7580
-
-
Missouri
-
Kansas City, Missouri, Estados Unidos, 64108
- Recrutamento
- Truman Medical Center ( Site 0126)
-
Contato:
- Study Coordinator
- Número de telefone: 816-404-4093
-
Springfield, Missouri, Estados Unidos, 65807
- Recrutamento
- Cox Medical Center North ( Site 0133)
-
Contato:
- Study Coordinator
- Número de telefone: 417-875-3000
-
-
Montana
-
Billings, Montana, Estados Unidos, 59102
- Recrutamento
- St. Vincent Frontier Cancer Center-Research ( Site 0105)
-
Contato:
- Study Coordinator
- Número de telefone: 402-238-6685
-
-
New Jersey
-
Morristown, New Jersey, Estados Unidos, 07960
- Concluído
- Atlantic Health System Morristown Medical Center ( Site 0121)
-
-
New York
-
Albany, New York, Estados Unidos, 12206
- Recrutamento
- New York Oncology Hematology, P.C. ( Site 0132)
-
Contato:
- Study Coordinator
- Número de telefone: 518-489-3612
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45219
- Recrutamento
- University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
-
Contato:
- Study Coordinator
- Número de telefone: 513-556-6000
-
Kettering, Ohio, Estados Unidos, 45429
- Concluído
- Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
-
-
Pennsylvania
-
Lancaster, Pennsylvania, Estados Unidos, 17601
- Recrutamento
- Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
-
Contato:
- Study Coordinator
- Número de telefone: 717-544-9400
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Recrutamento
- Oncology Consultants P.A. ( Site 0113)
-
Contato:
- Study Coordinator
- Número de telefone: 713-600-0900
-
-
Wisconsin
-
Madison, Wisconsin, Estados Unidos, 53715
- Recrutamento
- Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
-
Contato:
- Study Coordinator
- Número de telefone: 608-410-2767
-
-
-
-
National Capital Region
-
Pasig, National Capital Region, Filipinas, 1600
- Recrutamento
- The Medical City ( Site 3507)
-
Contato:
- Study Coordinator
- Número de telefone: (02)6356789 loc 5083
-
Quezon City, National Capital Region, Filipinas, 1100
- Recrutamento
- Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
-
Contato:
- Study Coordinator
- Número de telefone: +632 892 46101*1309
-
Quezon City, National Capital Region, Filipinas, 1102
- Recrutamento
- ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
-
Contato:
- Study Coordinator
- Número de telefone: +63287230101
-
Quezon City, National Capital Region, Filipinas, 1100
- Ativo, não recrutando
- Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
-
-
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, França, 06000
- Recrutamento
- Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
-
Contato:
- Study Coordinator
- Número de telefone: +33492038281
-
-
Bourgogne-Franche-Comté
-
Dijon, Bourgogne-Franche-Comté, França, 21000
- Recrutamento
- Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
-
Contato:
- Study Coordinator
- Número de telefone: +33380293772
-
-
Gard
-
Nîmes, Gard, França, 30029
- Recrutamento
- Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
-
Contato:
- Study Coordinator
- Número de telefone: +33 4 66 68 32 21
-
-
Nord
-
Valenciennes, Nord, França, 59304
- Recrutamento
- Clinique Teissier Groupe ( Site 1100)
-
Contato:
- Study Coordinator
- Número de telefone: +33327142337
-
-
Puy-de-Dome
-
Clermont-Ferrand, Puy-de-Dome, França, 63003
- Recrutamento
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
-
Contato:
- Study Coordinator
- Número de telefone: +33473278005
-
-
Vaucluse
-
Avignon, Vaucluse, França, 84000
- Recrutamento
- Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
-
Contato:
- Study Coordinator
- Número de telefone: +33432753333
-
-
Île-de-France Region
-
Boulogne-Billancourt, Île-de-France Region, França, 92100
- Recrutamento
- Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
-
Contato:
- Study Coordinator
- Número de telefone: +33149095806
-
-
-
-
-
Tbilisi, Geórgia, 0112
- Recrutamento
- Todua Clinic, LLC ( Site 1204)
-
Contato:
- Study Coordinator
- Número de telefone: +995322575757
-
Tbilisi, Geórgia, 0162
- Recrutamento
- New Hospitals ( Site 1200)
-
Contato:
- Study Coordinator
- Número de telefone: +995 598 988 566
-
Tbilisi, Geórgia, 0177
- Recrutamento
- Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
-
Contato:
- Study Coordinator
- Número de telefone: +995322430100
-
Tbilisi, Geórgia, 0102
- Recrutamento
- American Hospital Network LLC ( Site 1208)
-
Contato:
- Study Coordinator
- Número de telefone: +995 571 300 705
-
Tbilisi, Geórgia, 1206
- Concluído
- Tbilisi Institute of Medicine ( Site 1206)
-
Tbilisi, Geórgia, 0144
- Concluído
- TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
-
Tbilisi, Geórgia, 0159
- Recrutamento
- "Institute of Clinical Oncology" LTD ( Site 1210)
-
Contato:
- Study Coordinator
- Número de telefone: +995599406920
-
-
Adjara
-
Batumi, Adjara, Geórgia, 6000
- Recrutamento
- High Technology Hospital Medcenter ( Site 1203)
-
Contato:
- Study Coordinator
- Número de telefone: +995596226060
-
Tbilisi, Adjara, Geórgia, 0186
- Recrutamento
- Caucasus Medical Centre ( Site 1202)
-
Contato:
- Study Coordinator
- Número de telefone: +995 597 550 140
-
-
Imereti
-
Kutaisi, Imereti, Geórgia, 4600
- Recrutamento
- JSC "Vian" ( Site 1211)
-
Contato:
- Study Coordinator
- Número de telefone: +995599705858
-
-
-
-
-
Thessaloniki, Grécia, 570 10
- Recrutamento
- G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
-
Contato:
- Study Coordinator
- Número de telefone: 0030 231330787476
-
Thessaloniki, Grécia, 570 01
- Recrutamento
- European Interbalkan Medical Center ( Site 1404)
-
Contato:
- Study Coordinator
- Número de telefone: +302310380000
-
-
Achaia
-
Pátrai, Achaia, Grécia, 26504
- Recrutamento
- UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
-
Contato:
- Study Coordinator
- Número de telefone: +302610999791
-
-
Attica
-
Athens, Attica, Grécia, 115 27
- Recrutamento
- THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
-
Contato:
- Study Coordinator
- Número de telefone: +302107700220
-
Athens, Attica, Grécia, 115 22
- Recrutamento
- Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
-
Contato:
- Study Coordinator
- Número de telefone: +302106409501
-
Marousi, Attica, Grécia, 151 25
- Recrutamento
- Athens Medical Center ( Site 1406)
-
Contato:
- Study Coordinator
- Número de telefone: +302107464642
-
Piraeus, Attica, Grécia, 185 37
- Recrutamento
- Metaxa Cancer Hospital of Piraeus ( Site 1408)
-
Contato:
- Study Coordinator
- Número de telefone: +302132079225
-
-
Thessaly
-
Larissa, Thessaly, Grécia, 411 10
- Recrutamento
- University General Hospital of Larissa-Oncology Clinic ( Site 1403)
-
Contato:
- Study Coordinator
- Número de telefone: +302413502124
-
-
-
-
-
Utrecht, Holanda, 3584 CX
- Recrutamento
- Universitair Medisch Centrum Utrecht ( Site 1704)
-
Contato:
- Study Coordinator
- Número de telefone: 00318875555555
-
-
Gelderland
-
Ede, Gelderland, Holanda, 6716 RP
- Recrutamento
- Ziekenhuis Gelderse Vallei ( Site 1705)
-
Contato:
- Study Coordinator
- Número de telefone: 0318435499
-
Harderwijk, Gelderland, Holanda, 3844 DG
- Recrutamento
- Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
-
Contato:
- Study Coordinator
- Número de telefone: 0031341463504
-
-
Overijssel
-
Hengelo, Overijssel, Holanda, 7555 DL
- Recrutamento
- Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
-
Contato:
- Study Coordinator
- Número de telefone: +31887087878
-
Zwolle, Overijssel, Holanda, 8025 AB
- Recrutamento
- Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
-
Contato:
- Study Coordinator
- Número de telefone: 0031886243254
-
-
-
-
-
Padova, Itália, 35131
- Recrutamento
- IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
-
Contato:
- Study Coordinator
- Número de telefone: +390498215649
-
-
Campania
-
Naples, Campania, Itália, 80131
- Recrutamento
- Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
-
Contato:
- Study Coordinator
- Número de telefone: +390811777029
-
-
Emilia-Romagna
-
Ravenna, Emilia-Romagna, Itália, 48121
- Recrutamento
- Ospedale Santa Maria delle Croci ( Site 1606)
-
Contato:
- Study Coordinator
- Número de telefone: +390544285247
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, Itália, 33081
- Recrutamento
- CRO-IRCCS-Clinical Oncology ( Site 1605)
-
Contato:
- Study Coordinator
- Número de telefone: +390434309464
-
-
Lazio
-
Rome, Lazio, Itália, 00168
- Recrutamento
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
-
Contato:
- Study Coordinator
- Número de telefone: 00390630156318
-
-
Lombardy
-
Milan, Lombardy, Itália, 20133
- Recrutamento
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
-
Contato:
- Study Coordinator
- Número de telefone: +390223903829
-
Milan, Lombardy, Itália, 20141
- Recrutamento
- Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
-
Contato:
- Study Coordinator
- Número de telefone: +390257489482
-
-
Napoli
-
Naples, Napoli, Itália, 80131
- Recrutamento
- A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
-
Contato:
- Study Coordinator
- Número de telefone: 0817062652
-
-
Roma
-
Rome, Roma, Itália, 00144
- Recrutamento
- Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
-
Contato:
- Study Coordinator
- Número de telefone: +390652662205
-
-
Tuscany
-
Livorno, Tuscany, Itália, 57124
- Recrutamento
- Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
-
Contato:
- Study Coordinator
- Número de telefone: 00390586223416
-
-
-
-
-
Chiba, Japão, 260-8677
- Recrutamento
- Chiba University Hospital ( Site 3322)
-
Contato:
- Study Coordinator
- Número de telefone: +81-43-222-7171
-
Hiroshima, Japão, 730-8518
- Recrutamento
- Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
-
Contato:
- Study Coordinator
- Número de telefone: +81-82-221-2291
-
Kumamoto, Japão, 861-4193
- Recrutamento
- Saiseikai Kumamoto Hospital ( Site 3318)
-
Contato:
- Study Coordinator
- Número de telefone: +81-96-351-8000
-
Niigata, Japão, 951-8520
- Recrutamento
- Niigata University Medical & Dental Hospital ( Site 3323)
-
Contato:
- Study Coordinator
- Número de telefone: +81-25-223-6161
-
Osaka, Japão, 545-8586
- Recrutamento
- Osaka Metropolitan University Hospital ( Site 3321)
-
Contato:
- Study Coordinator
- Número de telefone: +81-6-6645-2121
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japão, 466-8560
- Recrutamento
- Nagoya University Hospital ( Site 3309)
-
Contato:
- Study Coordinator
- Número de telefone: +81-52-741-2111
-
Toyoake, Aichi-ken, Japão, 470-1192
- Recrutamento
- Fujita Health University Hospital ( Site 3310)
-
Contato:
- Study Coordinator
- Número de telefone: +81-562-93-2111
-
-
Chiba
-
Kashiwa, Chiba, Japão, 277-8577
- Recrutamento
- National Cancer Center Hospital East ( Site 3303)
-
Contato:
- Study Coordinator
- Número de telefone: +81-4-7133-1111
-
-
Ehime
-
Matsuyam, Ehime, Japão, 719-0280
- Recrutamento
- National Hospital Organization Shikoku Cancer Center ( Site 3315)
-
Contato:
- Study Coordinator
- Número de telefone: +81-89-999-1111
-
-
Fukuoka
-
Fukuoka, Fukuoka, Japão, 811-1395
- Recrutamento
- National Hospital Organization Kyushu Cancer Center ( Site 3316)
-
Contato:
- Study Coordinator
- Número de telefone: +81-92-541-3231
-
Kurume, Fukuoka, Japão, 830-0011
- Recrutamento
- Kurume University Hospital ( Site 3317)
-
Contato:
- Study Coordinator
- Número de telefone: +81-942-35-3311
-
-
Gunma
-
Ōta, Gunma, Japão, 373-8550
- Recrutamento
- Gunma Prefectural Cancer Center ( Site 3302)
-
Contato:
- Study Coordinator
- Número de telefone: +81-276-38-0771
-
-
Hokkaido
-
Sapporo, Hokkaido, Japão, 060-8543
- Recrutamento
- Sapporo Medical University Hospital ( Site 3324)
-
Contato:
- Study Coordinator
- Número de telefone: +81-11-611-2111
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japão, 920-8641
- Recrutamento
- Kanazawa University Hospital ( Site 3308)
-
Contato:
- Study Coordinator
- Número de telefone: +81-76-265-2000
-
-
Kanagawa
-
Kawasaki, Kanagawa, Japão, 216-8511
- Recrutamento
- St. Marianna University Hospital ( Site 3320)
-
Contato:
- Study Coordinator
- Número de telefone: +81-44-977-8111
-
-
Mie-ken
-
Matsusaka, Mie-ken, Japão, 515-8544
- Recrutamento
- Saiseikai Matsusaka Municipal Hospital ( Site 3311)
-
Contato:
- Study Coordinator
- Número de telefone: +81-598-23-1515
-
-
Miyagi
-
Natori-shi, Miyagi, Japão, 981-1293
- Recrutamento
- Miyagi Cancer Center ( Site 3301)
-
Contato:
- Study Coordinator
- Número de telefone: +81-22-384-3151
-
Sendai, Miyagi, Japão, 981-0914
- Recrutamento
- Sendai Kousei Hospital ( Site 3300)
-
Contato:
- Study Coordinator
- Número de telefone: +81-22-222-6181
-
-
Osaka
-
Hirakata, Osaka, Japão, 573-1191
- Recrutamento
- Kansai Medical University Hospital ( Site 3312)
-
Contato:
- Study Coordinator
- Número de telefone: +81-72-804-0101
-
Takatsuki, Osaka, Japão, 569-8686
- Recrutamento
- Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
-
Contato:
- Study Coordinator
- Número de telefone: +81-72-683-1221
-
-
Saitama
-
Kitaadachi-gun, Saitama, Japão, 362-0806
- Recrutamento
- Saitama Prefectural Cancer Center ( Site 3304)
-
Contato:
- Study Coordinator
- Número de telefone: +81-48-722-1111
-
-
Tokyo
-
Bunkyo, Tokyo, Japão, 113-8603
- Recrutamento
- Nippon Medical School Hospital ( Site 3306)
-
Contato:
- Study Coordinator
- Número de telefone: +81-3-3822-2131
-
Shinjuku, Tokyo, Japão, 160-0023
- Recrutamento
- Tokyo Medical University Hospital ( Site 3307)
-
Contato:
- Study Coordinator
- Número de telefone: +81-3-3342-6111
-
Shinjuku, Tokyo, Japão, 162-8655
- Recrutamento
- National Center for Global Health and Medicine ( Site 3305)
-
Contato:
- Study Coordinator
- Número de telefone: +81-3-3202-7181
-
Ōta-ku, Tokyo, Japão, 143-8541
- Recrutamento
- Toho University Omori Medical Center ( Site 3319)
-
Contato:
- Study Coordinator
- Número de telefone: +81-3-3762-4151
-
-
-
-
-
México, México, 14080
- Recrutamento
- Instituto Nacional de Cancerologia. ( Site 0608)
-
Contato:
- Study Coordinator
- Número de telefone: +525556280400
-
Oaxaca City, México, 68000
- Recrutamento
- Oaxaca Site Management Organization S.C. ( Site 0603)
-
Contato:
- Study Coordinator
- Número de telefone: +529515147056
-
-
Mexico City
-
Mexico City, Mexico City, México, 06700
- Recrutamento
- Arké SMO S.A. de C.V. ( Site 0602)
-
Contato:
- Study Coordinator
- Número de telefone: 5533345856
-
-
Nuevo León
-
Monterrey, Nuevo León, México, 66460
- Recrutamento
- Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
-
Contato:
- Study Coordinator
- Número de telefone: +528180883663
-
-
-
-
-
Auckland, Nova Zelândia, 1023
- Recrutamento
- Auckland City Hospital ( Site 3400)
-
Contato:
- Study Coordinator
- Número de telefone: +6493074949
-
-
-
-
-
Lima, Peru, 15036
- Recrutamento
- IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
-
Contato:
- Study Coordinator
- Número de telefone: 511 2241598 anex 121
-
-
-
-
Lesser Poland Voivodeship
-
Gorlice, Lesser Poland Voivodeship, Polônia, 38-300
- Concluído
- Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
-
Krakow, Lesser Poland Voivodeship, Polônia, 30-727
- Concluído
- Pratia MCM Krakow ( Site 1808)
-
-
Lublin Voivodeship
-
Lublin, Lublin Voivodeship, Polônia, 20-090
- Recrutamento
- Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
-
Contato:
- Study Coordinator
- Número de telefone: +48 814485180
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polônia, 02-781
- Recrutamento
- Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1800)
-
Contato:
- Study Coordinator
- Número de telefone: +48225462336
-
-
Podkarpackie Voivodeship
-
Przemyśl, Podkarpackie Voivodeship, Polônia, 37-700
- Recrutamento
- Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
-
Contato:
- Study Coordinator
- Número de telefone: +48166775000
-
-
Warmian-Masurian Voivodeship
-
Olsztyn, Warmian-Masurian Voivodeship, Polônia, 10-357
- Recrutamento
- Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
-
Contato:
- Study Coordinator
- Número de telefone: +48895322978
-
-
-
-
Buckinghamshire
-
Milton Keynes, Buckinghamshire, Reino Unido, MK6 5LD
- Recrutamento
- Milton Keynes Hospital ( Site 2304)
-
Contato:
- Study Coordinator
- Número de telefone: 01908 997609
-
-
Devon
-
Exeter, Devon, Reino Unido, EX2 5DW
- Recrutamento
- Royal Devon & Exeter Hospital-Oncology ( Site 2302)
-
Contato:
- Study Coordinator
- Número de telefone: +44 (0) 1392 402869
-
-
-
-
-
Brasov, Romênia, 500052
- Recrutamento
- SC ONCO CARD SRL ( Site 1995)
-
Contato:
- Study Coordinator
- Número de telefone: +40268 994
-
Bucharest, Romênia, 077190
- Recrutamento
- SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
-
Contato:
- Study Coordinator
- Número de telefone: +40722927377
-
Cluj-Napoca, Romênia, 400015
- Recrutamento
- Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
-
Contato:
- Study Coordinator
- Número de telefone: +40264598362
-
Suceava, Romênia, 720214
- Recrutamento
- Sigmedical Services SRL ( Site 1997)
-
Contato:
- Study Coordinator
- Número de telefone: +4 0330 803 483
-
-
Bucharest
-
Bucharest, Bucharest, Romênia, 020335
- Recrutamento
- Centrul de Diagnostic si Tratament Provita. ( Site 1992)
-
Contato:
- Study Coordinator
- Número de telefone: +4021.9432
-
-
Dolj
-
Craiova, Dolj, Romênia, 200542
- Recrutamento
- Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
-
Contato:
- Study Coordinator
- Número de telefone: +40731604432
-
-
Timiș County
-
Timișoara, Timiș County, Romênia, 300239
- Recrutamento
- Cabinet Medical Oncomed ( Site 1998)
-
Contato:
- Study Coordinator
- Número de telefone: +40356460995
-
-
-
-
-
Adana, Turquia (Türkiye), 01140
- Recrutamento
- Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
-
Contato:
- Study Coordinator
- Número de telefone: +90 322 456 19 00
-
Ankara, Turquia (Türkiye), 06010
- Recrutamento
- SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
-
Contato:
- Study Coordinator
- Número de telefone: +905058726378
-
Ankara, Turquia (Türkiye), 06230
- Recrutamento
- Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
-
Contato:
- Study Coordinator
- Número de telefone: +90 312 305 10 80
-
Ankara, Turquia (Türkiye), 06520
- Recrutamento
- Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
-
Contato:
- Study Coordinator
- Número de telefone: +903122536666
-
Ankara, Turquia (Türkiye), 06800
- Recrutamento
- Ankara Bilkent Şehir Hastanesi ( Site 2100)
-
Contato:
- Study Coordinator
- Número de telefone: +903125526000
-
Istanbul, Turquia (Türkiye), 34214
- Recrutamento
- Medipol Mega Universite Hastanesi-oncology ( Site 2105)
-
Contato:
- Study Coordinator
- Número de telefone: +902124447044
-
Istanbul, Turquia (Türkiye), 34722
- Recrutamento
- TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
-
Contato:
- Study Coordinator
- Número de telefone: +902166065200
-
Sakarya, Turquia (Türkiye), 54290
- Recrutamento
- Sakarya Training and Research Hospital ( Site 2109)
-
Contato:
- Study Coordinator
- Número de telefone: +902648884000
-
-
İzmir
-
Balçova, İzmir, Turquia (Türkiye), 35340
- Recrutamento
- Dokuz Eylul Universitesi Hastanesi ( Site 2108)
-
Contato:
- Study Coordinator
- Número de telefone: +902323434343
-
Bornova, İzmir, Turquia (Türkiye), 35100
- Recrutamento
- Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
-
Contato:
- Study Coordinator
- Número de telefone: +905322202675
-
-
-
-
Cherkasy Oblast
-
Cherkasy, Cherkasy Oblast, Ucrânia, 18009
- Concluído
- COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
-
-
Chernivetska Oblast
-
Chernivtsi, Chernivetska Oblast, Ucrânia, 58013
- Recrutamento
- Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
-
Contato:
- Study Coordinator
- Número de telefone: +380955077568
-
-
Dnipropetrovsk Oblast
-
Kryvyi Rih, Dnipropetrovsk Oblast, Ucrânia, 50000
- Recrutamento
- Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
-
Contato:
- Study Coordinator
- Número de telefone: +380973567855
-
-
Ivano-Frankivsk Oblast
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ucrânia, 76018
- Recrutamento
- Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
-
Contato:
- Study Coordinator
- Número de telefone: +380978411455
-
-
Kirovohrad Oblast
-
Kropyvnytskyi, Kirovohrad Oblast, Ucrânia, 25011
- Recrutamento
- Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
-
Contato:
- Study Coordinator
- Número de telefone: +380508412400
-
-
Kyivska Oblast
-
Kiev, Kyivska Oblast, Ucrânia, 03022
- Recrutamento
- Medical Center "MedOffice Group" ( Site 2219)
-
Contato:
- Study Coordinator
- Número de telefone: +380503858689
-
Kyiv, Kyivska Oblast, Ucrânia, 03039
- Recrutamento
- LLC Clinic Verum Expert ( Site 2223)
-
Contato:
- Study Coordinator
- Número de telefone: +380443835959
-
-
Lviv Oblast
-
Lviv, Lviv Oblast, Ucrânia, 79059
- Recrutamento
- Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
-
Contato:
- Study Coordinator
- Número de telefone: +380506749772
-
-
Rivne Oblast
-
Rivne, Rivne Oblast, Ucrânia, 33007
- Concluído
- Rivne Regional Clinical Hospital ( Site 2205)
-
Rivne, Rivne Oblast, Ucrânia, 33010
- Recrutamento
- ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
-
Contato:
- Study Coordinator
- Número de telefone: +380362633075
-
-
Vinnytsia Oblast
-
Vinnytsia, Vinnytsia Oblast, Ucrânia, 21029
- Recrutamento
- Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
-
Contato:
- Study Coordinator
- Número de telefone: +380953105783
-
-
Volyn Oblast
-
Lutsk, Volyn Oblast, Ucrânia, 43018
- Recrutamento
- ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
-
Contato:
- Study Coordinator
- Número de telefone: +380503782998
-
-
-
-
-
Vienna, Áustria, 1210
- Recrutamento
- Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
-
Contato:
- Study Coordinator
- Número de telefone: 0043 1 27700 72212
-
-
Styria
-
Graz, Styria, Áustria, 8036
- Recrutamento
- Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
-
Contato:
- Study Coordinator
- Número de telefone: 004331638512183
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, Índia, 400012
- Recrutamento
- Tata Memorial Hospital ( Site 3205)
-
Contato:
- Study Coordinator
- Número de telefone: 02224177000
-
Mumbai, Maharashtra, Índia, 400004
- Ativo, não recrutando
- Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, Índia, 110076
- Recrutamento
- Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
-
Contato:
- Study Coordinator
- Número de telefone: +919426166688
-
New Delhi, National Capital Territory of Delhi, Índia, 110029
- Recrutamento
- AIIMS New Delhi Dept of Medicine ( Site 3206)
-
Contato:
- Study Coordinator
- Número de telefone: +91-9650629370
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
The main inclusion and exclusion criteria include but are not limited to the following:
Inclusion Criteria:
- Has histologically or cytologically confirmed diagnosis of non-small cell lung cancer (NSCLC)
- Has newly diagnosed Stage IIIB/IIIC NSCLC, not eligible for curative resection or curative chemotherapy/radiation as determined by a multidisciplinary tumor board and/or by radiation oncologist, surgeon, and medical oncologist or Stage IV (M1a, M1b, or M1c) by American Joint Committee on Cancer (AJCC) Staging Manual, Version 8
- Provides an archival tumor sample (≤5 years) or newly obtained core, incisional, or excisional biopsy or fine needle aspirate (FNA) of a tumor lesion, not previously irradiated to enable central laboratory testing of kirsten rat sarcoma (KRAS) G12C mutation status, programmed cell death ligand 1 (PD-L1) status, and biomarker research
- If have had adverse events (AEs) due to previous anticancer therapies, must have recovered to < Grade 1 or baseline
- If human immunodeficiency virus (HIV)-infected, must have well controlled HIV on antiretroviral therapy (ART)
- If Hepatitis B surface antigen (HBsAg) positive, have received Hepatitis B Virus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
- If a participant has a history of Hepatitis C virus (HCV) infection, HCV viral load is undetectable
Exclusion Criteria:
- Has diagnosis of small cell lung cancer. For mixed tumors, if small cell elements are present, the participant is ineligible
- Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease
- Has known history of, or active, neurologic paraneoplastic syndrome
- Has an active infection requiring systemic therapy, with exceptions
- Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
- Has received prior systemic anticancer therapy for their locally advanced or metastatic NSCLC
- Has received radiation therapy to the lung that is >30 Gray within 6 months of start of study intervention
- Has received radiotherapy to non-central nervous system (CNS) disease within 2 weeks of start of study intervention. Participants must have recovered from all radiation-related toxicities, not required corticosteroids, and not have had radiation pneumonitis
- Has known active CNS metastases and/or carcinomatous meningitis
- Known additional malignancy that is progressing or has required active treatment within the past 3 years
- Has active autoimmune disease that has required systemic treatment in the past 2 years
- Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease
- Is HIV-infected and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease
- Has history of allogenic tissue/solid organ transplant
- Has not fully recovered from any effects of major surgical procedure
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Calderasib with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and calderasib by oral tablets until discontinuation criterion is met. |
IV infusion
Outros nomes:
Oral tablets
Outros nomes:
|
|
Comparador Ativo: Placebo with Pembrolizumab
Participants receive pembrolizumab 200 mg via intravenous (IV) infusion on Day 1 of each 21-day cycle (q3w) for up to 35 cycles and placebo by oral tablets once daily until discontinuation criterion is met. |
IV infusion
Outros nomes:
Oral tablets |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Progression-Free Survival (PFS)
Prazo: Up to approximately 42 months
|
PFS is defined as the time from randomization until either documented disease progression per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) or death due to any cause, whichever occurs first. PFS as determined by blinded independent central review (BICR) will be presented. |
Up to approximately 42 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Overall Survival
Prazo: Up to approximately 57 months
|
OS is defined as the time from randomization to death due to any cause. |
Up to approximately 57 months
|
|
Objective Response Rate (ORR)
Prazo: Up to approximately 42 months
|
ORR is defined as the percentage of participants with Complete Response or Partial Response per RECIST1.1. The percentage of participants who experience CR or PR as assessed by BICR will be presented. |
Up to approximately 42 months
|
|
Duration of Response (DOR)
Prazo: Up to approximately 42 months
|
For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first. |
Up to approximately 42 months
|
|
Number of Participants Who Experience One or More Adverse Event (AEs)
Prazo: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who experience an AE will be presented. |
Up to approximately 80 months
|
|
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event (AE)
Prazo: Up to approximately 80 months
|
An AE is any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a preexisting condition that is temporally associated with the use of the Sponsor's product, is also an AE. The number of participants who discontinue study treatment due to an AE will be presented. |
Up to approximately 80 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) Global Health Status (Item 29) and Quality of Life (Item 30) Combined Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. Higher scores indicate a better overall health status. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Physical Functioning (Items 1-5) Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 1-5 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Role Functioning (Items 6-7) Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Items 6-7 will be presented. Higher scores indicate a better level of functioning. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-C30 Dyspnea (Item 8) Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. A higher score indicates a worse level of dyspnea. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module (EORTC QLQ-LC13) Cough (Item 31) Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. A higher score indicates more frequent coughing. |
Baseline and Up to approximately 24 months
|
|
Change From Baseline in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Prazo: Baseline and Up to approximately 24 months
|
The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). The change from baseline in the score of EORTC QLQ-C13 Item 40 will be presented. A higher score indicates a worse level of chest pain. |
Baseline and Up to approximately 24 months
|
|
Time to Deterioration (TTD) in EORTC-QLQ-C30 Global Health Status (Item 29) Quality of Life (Item 30) Combined Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in global health status (GHS) and quality of life (QoL) (EORTC QLQ-C30 Items 29 and 30) score. Participant responses to the questions "How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?" are scored on a 7-point scale (1= Very poor to 7=Excellent). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in GHS and QoL, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Physical Functioning (Items 1-5) Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in physical functioning (EORTC QLQ-C30 Items 1-5) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 5 questions about their physical functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in physical functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Role Functioning (Items 6-7) Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in role functioning (EORTC QLQ-C30 Items 6 and 7) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant responses to 2 questions about their role functioning are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in role functioning score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC-QLQ-C30 Dyspnea (Item 8) Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in dyspnea (EORTC QLQ-C30 Item 8) score. The EORTC QLQ-C30 is a questionnaire to assess the overall quality of life of cancer patients. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in dyspnea score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Cough (Item 31) Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in cough (EORTC QLQ-C13 Item 31) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline in cough score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
|
TTD in EORTC QLQ-LC13 Chest Pain (Item 40) Score
Prazo: Baseline and Up to approximately 24 months
|
TTD is defined as the time from baseline to the first onset of a ≥10-point negative change (decrease) from baseline in chest pain (EORTC QLQ-C13 Item 40) score. The EORTC QLQ-C13 is lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The TTD, as assessed based on a ≥10 point negative change (decrease) from baseline chest pain score, will be presented. A longer TTD indicates a better outcome. |
Baseline and Up to approximately 24 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Medical Director, Merck Sharp & Dohme LLC
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Neoplasias por local
- Neoplasias
- Doenças Respiratórias
- Doenças pulmonares
- Neoplasias do Trato Respiratório
- Neoplasias Torácicas
- Neoplasias Pulmonares
- Carcinoma Broncogênico
- Neoplasias Brônquicas
- Carcinoma pulmonar de células não pequenas
- Doença de Parkinson 4, Corpo Autossômico Dominante de Lewy
- Pembrolizumab
Outros números de identificação do estudo
- 1084-004
- MK-1084-004 (Outro identificador: MSD)
- U1111-1296-8093 (Identificador de registro: UTN)
- jRCT2031240213 (Identificador de registro: jRCT)
- PHRR241128-007796 (Identificador de registro: PHRR)
- 2023-507776-42-00 (Identificador de registro: EU CT)
- KANDLELIT-004 (Outro identificador: MSD)
- 2023 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .